≥99% HPLCIntranasal spray

BPC Spray

Name: BPC Spray
Brand: Dripfy
Availability: InStock

What it is?

BPC Spray is an intranasal (nasal spray) delivery format of BPC-157 designed for needle-free application. It is positioned for protocols where convenience and non-injectable delivery are preferred, while maintaining a recovery-focused signalling profile; how much peptide is absorbed through the nasal mucosa has not been characterised in humans.

Dripfy Advantage

Intranasal delivery strategy: Delivered via the nasal mucosa as a needle-free route; absorption and the extent of systemic exposure via this route are not established in humans.
Non-injectable compliance: Designed for users and settings where injectable administration is not optimal, improving routine adherence.
Barrier and repair signalling: Positioned for tissue repair pathways relevant to wound recovery and inflammation balance in non-injectable protocols.
Convenience for consistent use: Spray format supports frequent, structured application, often critical for recovery routines.

Clinical Applications & Therapeutic Potential

Injury recovery support: Potential support for discomfort and inflammation-associated markers in minor injury contexts (research context; systemic uptake via the nasal route is uncharacterised).
Wound healing pathways: Positioned for the repair-signalling and recovery endpoints studied for BPC-157 in preclinical models.
Inflammation modulation: Potential reductions in inflammatory response markers with improved recovery comfort.
Injection-avoidant protocols: A practical option where non-invasive delivery is a requirement for the protocol design.

Composition & Formulation

Active peptide: BPC-157 (synthetic pentadecapeptide)
Formulation: Intranasal spray (aqueous buffered solution; preservative-controlled)

€496

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Intranasal spray
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

BPC Spray

Investigational intranasal BPC-157 (regenerative / cytoprotective), nasal spray format · Intranasal spray

D· Preliminary evidence

BPC Spray delivers the BPC-157 peptide as an intranasal (nasal) spray, a needle-free, non-injectable format. The proposed repair and inflammation-balancing signalling is the same as for BPC-157, but how much peptide is absorbed through the nasal mucosa and how much systemic exposure results is poorly characterised in humans. It should be regarded as investigational rather than an established treatment.

Studied use areas

Tissue-repair support (research context)
Non-injectable recovery routines where a needle-free route is preferred
Inflammation balance during recovery (studied)
Convenience-oriented, repeat intranasal application

Safety & status

Investigational and not an approved medicine; intranasal human data are essentially absent
Nasal absorption and systemic exposure are uncertain; intranasal use may cause local nasal irritation
Prohibited in competitive sport under the WADA non-approved-substance category
Use only under qualified physician oversight

⚕ Clinical note: This card is educational and is not medical advice. BPC Spray is an investigational intranasal form of BPC-157; any use must be individualised and supervised by the treating physician.

Evidence: Investigational — animal-derived rationale, intranasal human data essentially absent · References: peer-reviewed regenerative-medicine and preclinical tissue-repair literature; EMA/MHRA regulatory-status information on unapproved peptides; sports anti-doping (WADA) prohibited-substance listings